61 related articles for article (PubMed ID: 24623798)
1. GH administration patterns differently regulate epidermal growth factor signaling.
Díaz ME; Miquet JG; Rossi SP; Irene PE; Sotelo AI; Frungieri MB; Turyn D; González L
J Endocrinol; 2014 May; 221(2):309-23. PubMed ID: 24623798
[TBL] [Abstract][Full Text] [Related]
2. Plasma growth hormone pattern regulates epidermal growth factor (EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver.
Ekberg S; Carlsson L; Carlsson B; Billig H; Jansson JO
Endocrinology; 1989 Oct; 125(4):2158-66. PubMed ID: 2791983
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
Wiepz GJ; Houtman JC; Cha D; Bertics PJ
J Cell Physiol; 1997 Oct; 173(1):44-53. PubMed ID: 9326448
[TBL] [Abstract][Full Text] [Related]
4. GH modulates hepatic epidermal growth factor signaling in the mouse.
González L; Díaz ME; Miquet JG; Sotelo AI; Fernández D; Dominici FP; Bartke A; Turyn D
J Endocrinol; 2010 Mar; 204(3):299-309. PubMed ID: 20032199
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice.
Jansson JO; Ekberg S; Hoath SB; Beamer WG; Frohman LA
J Clin Invest; 1988 Dec; 82(6):1871-6. PubMed ID: 3264288
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of epidermal growth factor (EGF) signaling by growth hormone (GH).
González L; Miquet JG; Irene PE; Díaz ME; Rossi SP; Sotelo AI; Frungieri MB; Hill CM; Bartke A; Turyn D
J Endocrinol; 2017 May; 233(2):175-186. PubMed ID: 28223314
[TBL] [Abstract][Full Text] [Related]
7. Stage-sensitive blockade of pituitary somatomammotrope development by targeted expression of a dominant negative epidermal growth factor receptor in transgenic mice.
Roh M; Paterson AJ; Asa SL; Chin E; Kudlow JE
Mol Endocrinol; 2001 Apr; 15(4):600-13. PubMed ID: 11266511
[TBL] [Abstract][Full Text] [Related]
8. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
Waxman DJ; Ram PA; Pampori NA; Shapiro BH
Mol Pharmacol; 1995 Nov; 48(5):790-7. PubMed ID: 7476908
[TBL] [Abstract][Full Text] [Related]
11. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice overexpressing GH exhibit hepatic upregulation of GH-signaling mediators involved in cell proliferation.
Miquet JG; González L; Matos MN; Hansen CE; Louis A; Bartke A; Turyn D; Sotelo AI
J Endocrinol; 2008 Aug; 198(2):317-30. PubMed ID: 18480380
[TBL] [Abstract][Full Text] [Related]
13. Infusion of gender-dependent plasma growth hormone profiles into intact rats: effects of subcutaneous, intraperitoneal, and intravenous routes of rat and human growth hormone on endogenous circulating growth hormone profiles and expression of sexually dimorphic hepatic cyp isoforms.
Pampori NA; Agrawal AK; Shapiro BH
Drug Metab Dispos; 2001 Jan; 29(1):8-16. PubMed ID: 11124223
[TBL] [Abstract][Full Text] [Related]
14. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
15. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.
Ahmad N; Gali H; Javed S; Agarwal R
Biochem Biophys Res Commun; 1998 Jun; 247(2):294-301. PubMed ID: 9642119
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
17. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
18. Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.
Hurtado M; Lozano JJ; Castellanos E; López-Fernández LA; Harshman K; Martínez-A C; Ortiz AR; Thomson TM; Paciucci R
Gut; 2007 Sep; 56(9):1266-74. PubMed ID: 17452424
[TBL] [Abstract][Full Text] [Related]
19. Abuse of recombinant human growth hormone: studies in two different dog models.
Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
Song JY; Lee SW; Hong JP; Chang SE; Choe H; Choi J
Cancer Lett; 2009 Oct; 283(2):135-42. PubMed ID: 19380191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
